149 related articles for article (PubMed ID: 8008736)
1. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
3. [Clinico-pathological features and biological characterization of mucoid colorectal carcinoma].
Lanza G; Gafà R; Dubini A; Maestri I; Cavazzini L
Pathologica; 1995 Dec; 87(6):631-9. PubMed ID: 8927422
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
6. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.
Crissman JD; Zarbo RJ; Ma CK; Visscher DW
Pathol Annu; 1989; 24 Pt 2():103-47. PubMed ID: 2671879
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study.
Visscher DW; Zarbo RJ; Ma CK; Sakr WA; Crissman JD
Mod Pathol; 1990 Nov; 3(6):709-12. PubMed ID: 2263595
[TBL] [Abstract][Full Text] [Related]
9. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
[TBL] [Abstract][Full Text] [Related]
10. The DNA content of colorectal carcinomas: an analysis of the heterogeneity of aneuploidy and correlation with immunopathological parameters.
Zaloudík J; Moore M; Hasleton PS
Neoplasma; 1988; 35(4):389-401. PubMed ID: 3054589
[TBL] [Abstract][Full Text] [Related]
11. Correlation between DNA content and p53 deletion in colorectal cancer.
Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
[TBL] [Abstract][Full Text] [Related]
12. A model of DNA aneuploidization and evolution in colorectal cancer.
Giaretti W
Lab Invest; 1994 Dec; 71(6):904-10. PubMed ID: 7807972
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
[TBL] [Abstract][Full Text] [Related]
14. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
15. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.
Giaretti W; Monaco R; Pujic N; Rapallo A; Nigro S; Geido E
Am J Pathol; 1996 Jul; 149(1):237-45. PubMed ID: 8686748
[TBL] [Abstract][Full Text] [Related]
16. Cytometric ploidy and proliferative activity in colorectal carcinoma.
Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L
Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813
[TBL] [Abstract][Full Text] [Related]
17. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.
Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY
Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936
[TBL] [Abstract][Full Text] [Related]
18. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
20. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.
Tribukait B; Hammarberg C; Rubio C
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
